Astrobot’s S1 humanoid showcases unprecedented speed and dexterity in household tasks, marking a notable advancement in robotics.
The hypertension drug rilmenidine has been shown to slow down aging in worms, an effect that in humans could hypothetically help us live longer and keep us healthier in our latter years.
Previous research has shown rilmenidine mimics the effects of caloric restriction on a cellular level. Reducing available energy while maintaining nutrition within the body has been shown to extend lifespans in several animal models.
Whether this translates to human biology, or is a potential risk to our health, is a topic of ongoing debate. Finding ways to achieve the same benefits without the costs of extreme calorie cutting could lead to new ways to improve health in old age.
Russian military intelligence hackers have been exploiting a Windows vulnerability since at least 2020 according to a new Microsoft report. Here’s what you need to know.
Battery recycling drops from ~25,500 miles to ~15,000 miles the CO2 breakeven point for EVs compared to ICE.
Are electric cars really that much better for the environment? With recycling, the question is a no-brainer.
Irina Conboy, Michael Conboy and Josh Mitteldorf discuss one of the central questions in aging research: is aging an active process of the body or is aging a…
In our latest video, “Has The Future Already Happened? Is the Universe Predetermined?” we embark on a cosmic journey that challenges the very fabric of our u…
MEDIA ADVISORY: An international team of researchers, led by NCI scientists, has identified 50 new areas across the human genome that are associated with the risk of developing kidney cancer.
In a new analysis of genetic susceptibility to kidney cancer, an international team of researchers has identified 50 new areas across the genome that are associated with the risk of developing kidney cancer. These insights could one day be used to advance our understanding of the molecular basis of kidney cancer, inform screening efforts for those at highest risk, and identify new drug targets. The study was led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).
A previous genome-wide association study (GWAS) of people of European ancestry identified 13 regions of the genome that are associated with kidney cancer risk. However, the study population was not diverse. To identify additional regions, researchers conducted a GWAS in participants of many different genetic ancestries that included 29,020 people with kidney cancer and 835,670 people without kidney cancer. Analysis of the data, which came from published studies, biobanks, and a new study, resulted in the identification of 50 new regions associated with the risk of developing kidney cancer, bringing the total number of such regions to 63.
Continue reading “New study provides genomic insights into kidney cancer risk” »
Technology views living cancer cell:
This technique could provide valuable insights into how different types of cancer respond to treatments. It might also help doctors understand the impact of irradiation on cells, specifically how some cancer cells resist radiation treatment. This resistance may result in relapse of the cancer.
A deeper understanding of cancer biology may lead to the development of more effective treatments in the future.
Continue reading “In a first, scientists use new tech to see inside cancer cells” »
